Morandell, Sandra <br/><br/>
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo.  [electronic resource] 

 -  Cell reports  Nov 2013 
 - 868-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2013.10.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cisplatin--pharmacology<br/>DNA Damage--genetics<br/>DNA Repair--genetics<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Protein Serine-Threonine Kinases--genetics<br/>RNA Interference<br/>RNA, Small Interfering<br/>Tumor Suppressor Protein p53--genetics<br/>p38 Mitogen-Activated Protein Kinases--genetics